Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia

• Jorge J. Castillo,
• Joshua N. Gustine,
• Kirsten Meid,
• Toni Dubeau,
• Patricia Severns,
• Steven P. Treon

Affiliations

Jorge J. Castillo

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA

Joshua N. Gustine

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA

Kirsten Meid

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA

Toni Dubeau

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA

Patricia Severns

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA

Steven P. Treon

Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA;Harvard Medical School, Boston, MA, USA